Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • Innovate AI+Robotics Expo 2025 to Showcase Cutting-Edge Technologies in Cebu City
    Innovate AI+Robotics Expo 2025 to Showcase Cutting-Edge Technologies in Cebu City Business
  • WrkSpot CEO and Founder Raja Epsilon’s Software Improves Hotel Operations
    WrkSpot CEO and Founder Raja Epsilon’s Software Improves Hotel Operations Business
  • Lydia Fearing of Austin’s Law Office of Becky Beaver Awarded Super Lawyer Rising Star
    Lydia Fearing of Austin’s Law Office of Becky Beaver Awarded Super Lawyer Rising Star World News
  • Pipistrel Completes First eVTOL Flight of Nuuva V300 Cargo Drone
    Pipistrel Completes First eVTOL Flight of Nuuva V300 Cargo Drone Aviation
  • New Zealand Waitangi Day – United States Department of State
    New Zealand Waitangi Day – United States Department of State World News
  • Analytical Standards Market Size, Share And Growth Analysis For 2023-2032
    Analytical Standards Market Size, Share And Growth Analysis For 2023-2032 World News
  • John Galt Solutions’ Supply Chain Scholarship Now Open for Applications
    John Galt Solutions’ Supply Chain Scholarship Now Open for Applications Business
  • Legends of War – Book 2: Sparrow Wars in the Garden of Bliss, Presented by Atticus Publishing
    Legends of War – Book 2: Sparrow Wars in the Garden of Bliss, Presented by Atticus Publishing World News
Gb Sciences’ Plant-based Formulations Designed to Treat Anxiety Achieve Statistical Significance in Animal Study

Gb Sciences’ Plant-based Formulations Designed to Treat Anxiety Achieve Statistical Significance in Animal Study

Posted on October 24, 2022 By NewsEditor
Gb Sciences’ Plant-based Formulations Designed to Treat Anxiety Achieve Statistical Significance in Animal StudyGb Sciences’ Plant-based Formulations Designed to Treat Anxiety Achieve Statistical Significance in Animal StudyGb Sciences' anxiety formulations were previously identified using the company's AI-driven PhAROS™ platform, and they have now been evaluated using preclinical zebrafish models of stress at the National Research Council of Canada.

Gb Sciences’ Plant-based Formulations Designed to Treat Anxiety Achieve Statistical Significance in Animal Study
GB Sciences


LAS VEGAS - October 24, 2022 - (Newswire.com)

Gb Sciences, Inc. ("GbS"; OTCQB:GBLX), a leading plant-inspired research and biopharmaceutical drug development company, has received positive preclinical results in an interim report from its study using preclinical zebrafish models of stress at the National Research Council of Canada (NRC). GbS' proprietary anxiety formulations have achieved a statistically significant reduction of stress in this preclinical study. The NRC is testing GbS' proprietary, psychotropic plant-based formulas for the treatment of depression and anxiety. GbS has leveraged its patent-pending PhAROS™ (Phytomedical Analytics for Research Optimization at Scale) platform to identify these combinations of plant compounds for novel drug candidates. These are the company's first non-cannabis formulations to advance in preclinical studies.

"We have achieved an important milestone in the development of our novel, kava-inspired anxiety formulations. Not only did some of our formulations achieve statistical significance in the animal model, but these minimum essential mixtures also demonstrated synergy by significantly outperforming the individual active ingredients within our minimum essential mixture formulations," said Dr. Andrea Small-Howard, Gb Sciences' President and Chief Science Officer. "This preclinical data also confirms that our PhAROS™ platform was capable of yielding concrete, potentially effective, plant-inspired combination drugs."

For these novel psychotropic drug candidates, the Gb Sciences research team used the PhAROS™ platform to identify new ingredients to improve upon an initial formulation for anxiety based on traditional medicine. The original plant mixture was derived from the kava plant, but some elements of kava are thought to cause liver toxicity. PhAROS™ identified ingredients from the Piper plant family as a substitute for the functionality of the ingredients in question without the potentially adverse safety profiles of those original ingredients. The Piper plant family includes pepper plants that are used worldwide in traditional medicines.

The PhAROSTM platform is a revolutionary, AI-driven science gateway and virtual research environment for drug discovery. With its data analytics and machine learning capabilities, PhAROS™ allows Gb Sciences to greatly reduce the time and money required to bring novel, plant-inspired formulations to market. PhAROS™ represents a breakthrough combination of data sciences and traditional plant-based medicines. 

To learn more about Gb Sciences, visit www.gbsciences.com.

About Gb Sciences and GbS Global Biopharma

Gb Sciences, Inc. is a plant-inspired, biopharmaceutical research and development company creating patented, disease-targeted formulations of cannabis- and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc. The 'plant-inspired' active ingredients in its therapeutic mixtures are synthetic homologues identical to the original plant compounds but produced under current Good Manufacturing Practices. Gb Sciences' intellectual property portfolio contains six issued U.S. and three issued foreign patents, as well as 17 U.S. and 51 foreign patent-pending applications. In its drug development pipeline, Gb Sciences has five preclinical phase product development programs. Gb Sciences' lead program for Parkinson's disease is being prepared for a first-in-human clinical trial. Gb Sciences' formulations for chronic pain, anxiety, and depression are currently in preclinical animal studies with researchers at the National Research Council of Canada (NRC). The company also received positive preclinical proof-of-concept data supporting its complex mixtures for the treatment of Cytokine Release Syndrome, and its lead candidates will be optimized based on late-stage preclinical studies at Michigan State University. Gb Sciences' productive research and development network includes distinguished universities, hospitals, and Contract Research Organizations. To learn more, visit www.gbsciences.com. 

Forward-Looking Statements

This press release may contain statements relating to future results or events, which are forward-looking statements. Words such as "expects," "intends," "plans," "may," "could," "should," "anticipates," "likely," "believes" and words of similar import may identify forward-looking statements. These statements are not historical facts, but instead represent only the Company's belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the Company's control. It is possible that the Company's actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements. Further, information concerning the Company and its business, including factors that potentially could materially affect the Company's business and financial and other results, are contained in the Company's filings with the Securities and Exchange Commission, available at www.sec.gov. All forward-looking statements included in this press release are made only as of the date of this press release, and we do not undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.

Media Contact

Alexis Quintal

[email protected]


Contact Information:
Madeleine Moench
[email protected]


Press Release Service by Newswire.com

Original Source: Gb Sciences' Plant-based Formulations Designed to Treat Anxiety Achieve Statistical Significance in Animal Study
Business

Post navigation

Previous Post: Genomes Partners With CariGenetics to Launch a Decentralized Lab for Breast Cancer Research
Next Post: NREP Launched New Emergency Planning Professional Certification

Related Posts

  • On-Screen Tours that Ignite Digital Growth for Local Businesses
    On-Screen Tours that Ignite Digital Growth for Local Businesses Business
  • ‘Comfort for All’ Company Announces New CEO
    ‘Comfort for All’ Company Announces New CEO Business
  • Mini Mall Storage Offers Drive Up Storage Units And Parking Spots For RVs, Boats, And Other Vehicles in Greencastle, IN
    Mini Mall Storage Offers Drive Up Storage Units And Parking Spots For RVs, Boats, And Other Vehicles in Greencastle, IN Business
  • Castle Connolly Releases Castle Connolly Top Black Doctors 2023
    Castle Connolly Releases Castle Connolly Top Black Doctors 2023 Business
  • How to Start a Profitable Golf Simulator Business: A Guide for Entrepreneurs
    How to Start a Profitable Golf Simulator Business: A Guide for Entrepreneurs Business
  • Augmenta AgTech and Torgerson’s LLC Announce Their Partnership
    Augmenta AgTech and Torgerson’s LLC Announce Their Partnership Business
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
« Jul    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • Augusta Precious Metals Ranked #1 in Industry ReportAugust 3, 2025
  • The National Space Society Mobilizes for the ‘Day of Action to Save NASA Science’August 3, 2025
  • Fremantle’s Original Productions to Give Away Bored Ape in Celebration of How The World Went Ape$h!t’s Stuff.io ReleaseAugust 3, 2025
  • Christmas Comes in July Thanks to First City Credit Union and KEVANI’s Generous Billboard Space DonationAugust 2, 2025
  • War in Ukraine, Analytics. Day 1243: Why American Aid Will Not Help. Arestovych, Shelest.August 2, 2025
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • EXIRIO Announces Launch of Premium Portfolio Tracking Services
    EXIRIO Announces Launch of Premium Portfolio Tracking Services Business
  • Honoring Boris Nemtsov – United States Department of State
    Honoring Boris Nemtsov – United States Department of State World News
  • Haltia.AI Assembles Elite Team with Over 200 Years of Experience, including Cypherpunks, PhD’s, and a Professor
    Haltia.AI Assembles Elite Team with Over 200 Years of Experience, including Cypherpunks, PhD’s, and a Professor World News
  • Industrial Tourism Market Size, Share, Revenue, Trends And Drivers For 2023-2032
    Industrial Tourism Market Size, Share, Revenue, Trends And Drivers For 2023-2032 World News
  • Chaka Khan and Stevie Wonder Battled at her Seventieth Birthday Bash
    Chaka Khan and Stevie Wonder Battled at her Seventieth Birthday Bash World News
  • Belle Lundon’s “Space Cadet (Remix)” Soars to #12 on US iTunes Pop Songs Chart
    Belle Lundon’s “Space Cadet (Remix)” Soars to #12 on US iTunes Pop Songs Chart World News
  • Director of a non-profit organization advances further in the Dream Chopper Competition, Aims to Be First Female Winner
    Director of a non-profit organization advances further in the Dream Chopper Competition, Aims to Be First Female Winner World News
  • Koios Provides a Current Update on Status of MCTO
    Koios Provides a Current Update on Status of MCTO Business
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195 News. All Rights Reserved by Coolaser | Partner of VUGA Enterprises |  Advertising: Get Published

Powered by .